ARLINGTON, Va., and BOSTON – The Personal Connected Health Alliance and the Digital Therapeutics Alliance have joined forces to further establish the field of digital therapeutics.
The partnership will combine the infrastructure, reach and resources of PCHAlliance and the expertise, thought leadership and focus of DTA.
“Digital therapeutics is an emerging trend, based on the idea that technology can improve an individual’s health as much as a drug can, as well as increase the efficacy of drug therapies,” said Patty Mechael, executive vice president of the PCHAlliance, in a statement. “We are pleased to partner with the Digital Therapeutics Alliance to combine our resources to advance the field, galvanize key stakeholders, focus on developing standards of quality, and work toward improving health outcomes through this newly developing sub-domain of personal connected health.”
The term “digital therapeutics” refers to digital technology or software to treat a medical condition, used alone and in combination with conventional drug therapies. Digital therapeutics include mobile apps, wearable sensors, health monitoring devices or software that can change an individual’s behavior to achieve positive clinical outcomes and better control the cost of care.
The PCHAlliance has also launched a new Digital Therapeutics Task Force, which will draw on DTA’s subject matter expertise to focus on an initial set of high priority projects for both organizations. The task force will be open to PCHAlliance member companies, as well as allied associations and non-corporate thought leaders by invitation only.
“Digital therapeutics companies are developing clinically validated tools that are improving value and lowering costs,” said Pierre Leurent, CEO of Voluntis, a PCHAlliance member organization, a founding member of the DTA and the task force’s chairman. “The field is evolving, so there is a need for digital therapeutics companies to come together, to clearly delineate the market, define the benefits and secure regulatory, reimbursement, provider and policy support.”